Prognosis of patients with endometrial cancer or atypical endometrial hyperplasia after complete remission with fertility-sparing therapy

PURPOSE: Although many patients with endometrial cancer (EC) or atypical endometrial hyperplasia (AEH) achieve complete remission (CR) after high-dose medroxyprogesterone acetate (MPA) treatment, no consensus has been reached on management after CR. Currently, patients receive estrogen-progestin mai...

Descripción completa

Detalles Bibliográficos
Autores principales: Ga, Hiromi, Taguchi, Ayumi, Honjoh, Harunori, Nishijima, Akira, Eguchi, Satoko, Miyamoto, Yuichiro, Sone, Kenbun, Mori, Mayuyo, Osuga, Yutaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Gynecologic Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520125/
https://www.ncbi.nlm.nih.gov/pubmed/37310452
http://dx.doi.org/10.1007/s00404-023-07077-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520125/
https://www.ncbi.nlm.nih.gov/pubmed/37310452
http://dx.doi.org/10.1007/s00404-023-07077-7

Ejemplares similares